Halozyme Therapeutics Inc (NASDAQ:HALO)

15.07
Delayed Data
As of Feb 27
 -0.21 / -1.37%
Today’s Change
6.88
Today|||52-Week Range
16.25
+56.17%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Halozyme Therapeutics Inc have a median target of 17.00, with a high estimate of 24.00 and a low estimate of 5.00. The median estimate represents a +12.81% increase from the last price of 15.07.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Halozyme Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.07
Sales
$25.6M
Reporting Date
Mar 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 56.83%
 
 
 
 
 
 
Growthannually 19.60%
 
 
 
 
 
 

Sales

Growthquarterly 75.20%
 
 
 
 
 
 
Growthannually 26.75%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account